Skip to main content
PLOS One logoLink to PLOS One
. 2021 Sep 30;16(9):e0257737. doi: 10.1371/journal.pone.0257737

Left ventricular longitudinal strain variations assessed by speckle-tracking echocardiography after a passive leg raising maneuver in patients with acute circulatory failure to predict fluid responsiveness: A prospective, observational study

Clemence Roy 1, Gary Duclos 1, Cyril Nafati 2, Mickael Gardette 2, Alexandre Lopez 1, Bruno Pastene 1, Eliott Gaudray 1, Alain Boussuges 3, François Antonini 1, Marc Leone 1, Laurent Zieleskiewicz 1,3,*
Editor: Robert Ehrman4
PMCID: PMC8483378  PMID: 34591884

Abstract

Background

An association was reported between the left ventricular longitudinal strain (LV-LS) and preload. LV-LS reflects the left cardiac function curve as it is the ratio of shortening over diastolic dimension. The aim of this study was to determine the sensitivity and specificity of LV-LS variations after a passive leg raising (PLR) maneuver to predict fluid responsiveness in intensive care unit (ICU) patients with acute circulatory failure (ACF).

Methods

Patients with ACF were prospectively included. Preload-dependency was defined as a velocity time integral (VTI) variation greater than 10% between baseline (T0) and PLR (T1), distinguishing the preload-dependent (PLD+) group and the preload-independent (PLD-) group. A 7-cycles, 4-chamber echocardiography loop was registered at T0 and T1, and strain analysis was performed off-line by a blind clinician. A general linear model for repeated measures was used to compare the LV-LS variation (T0 to T1) between the two groups.

Results

From June 2018 to August 2019, 60 patients (PLD+ = 33, PLD- = 27) were consecutively enrolled. The VTI variations after PLR were +21% (±8) in the PLD+ group and -1% (±7) in the PLD- group (p<0.01). Mean baseline LV-LS was -11.3% (±4.2) in the PLD+ group and -13.0% (±4.2) in the PLD- group (p = 0.12). LV-LS increased in the whole population after PLR +16.0% (±4.0) (p = 0.04). The LV-LS variations after PLR were +19.0% (±31) (p = 0.05) in the PLD+ group and +11.0% (±38) (p = 0.25) in the PLD- group, with no significant difference between the two groups (p = 0.08). The area under the curve for the LV-LS variations between T0 and T1 was 0.63 [0.48–0.77].

Conclusion

Our study confirms that LV-LS is load-dependent; however, the variations in LV-LS after PLR is not a discriminating criterion to predict fluid responsiveness of ICU patients with ACF in this cohort.

Introduction

Acute circulatory failure (ACF) is a major issue occurring in up to 65% of intensive care unit (ICU) patients [1]. ACF can result from several mechanisms (hypovolemic, cardiogenic, distributive shocks) requiring different interventions. Fluid resuscitation (FR) is the first-line treatment for patients with preload-dependency and is used to expand the intravascular compartment and thus improve cardiac output (CO) and end-organ perfusion [2, 3]. Clinical evaluation alone leads to inappropriate FR in up to 50% of cases [4, 5]. Yet, inappropriate FR has been associated with increased morbidity (i.e. acute respiratory failure, acute kidney injury, abdominal compartment syndrome) and mortality [610]. Therefore, FR should be guided by repeated assessments of patients’ hemodynamic status [2] using markers of preload-dependency to predict fluid responsiveness. Many preload-dependency markers have been studied recently, and those based on dynamic change of cardiac output or surrogates are considered as standard of care to evaluate preload-dependency in patients with ACF [11].

Among the existing preload-dependency markers, a variation greater than 10% in left ventricular outflow track velocity-time integral (LVOT-VTI) measured with transthoracic echocardiography (TTE) during a passive leg raising (PLR) maneuver is considered a reliable method [1115]. This marker is non-invasive, easily accessible at patients’ bedside in ICUs. However, the evaluation of the LVOT-VTI variations requires cautious interpretation due to its inter-individual variability [1618].

Longitudinal speckle-tracking strain echocardiography is widely used by cardiologists, especially in patients with heart failure [19, 20] and is increasingly used in ICUs [2124]. This technique is based on the tracking of acoustic markers (called speckle) within the myocardium during the cardiac cycle. This technology allows for an assessment of the myocardium strain during systole and diastole [25] and is a highly reproducible procedure, as shown by Negishi et al [26]. The longitudinal strain (LS) value for each myocardial segment is defined by the following formula: LS = (L-L0) /L0, where L is length of the segment during systole, and L0 is the length of the segment in end-diastole. The longitudinal strain has a negative value, with a normal range for the left ventricle (LV) of around -16% to -19% [27].

The aim of this technology is first to describe the systolic segmental function of the myocardium [28] but modified load conditions were found to be associated with modified LV-LS value, especially when changes in preload occur [21, 2933]. Nafati et al. evaluated the LV-LS in preload-dependent (PLD+) ICU patients and found a decreased mean LV global longitudinal strain (LV-GLS) value of -13.3% [21]. In this study, LV-GLS values normalized after FR, confirming that LV-GLS depends on preload conditions. Indeed, the longitudinal strain formula refers to myocardial fibers’ deformation. We attempted to assess the hypothesis suggesting that, when a PLD+ patient undergoes PLR, the result is an increased LV preload, and thus, an extension of “L0” (increased LV volume in end-diastole). A shortening of “L” during systole then ensues, by improvement of LV inotropism according to the Franck-Starling principle. Thus, PLD+ patients should have detectable LV longitudinal strain variations in TTE after PLR.

The aim of this study was thus to determine the sensitivity and specificity of LV-LS variations after PLR to predict fluid responsiveness in ICU patients with ACF, using LVOT-VTI variations after PLR as a reference method to assess preload dependency.

Methods

This study was prospective and observational and took place in a 15-beds ICU at North Hospital in Marseille, France from June 2018 to August 2019. The protocol was approved by the Ethics Committee of Amiens, France (IRB 2017-A03584-49, May 4, 2018). Informed written consent was obtained from either the patients or their relatives, after an oral and written information was delivered by the clinician, according to the French law [34]. Patients admitted to the ICU with ACF upon admission or during the ICU stay were screened. The inclusion criteria included any of the following clinical or biological features: arterial hypotension (systolic blood pressure < 90 mmHg or mean blood pressure (MAP) < 65 mmHg), urine output < 0.5 ml/kg/h, use of vasopressors to keep MAP > 65 mmHg, clinical signs of hypoperfusion (i.e. mottled skin) and serum lactate concentration > 2.0 mmol/l. Patients were either under mechanical ventilation, non-invasive ventilation or spontaneous breathing. The exclusion criteria included: age < 18 years, patient under guardianship, patient already included in another trial, arrythmia or non-sinus cardiac rhythm, mitral regurgitation, right ventricle (RV) heart failure, elevated left atrial pressure, cardiogenic pulmonary edema, restrictions on passive leg raising realization (unstable rachis trauma, intra-cranial hypertension, pericardial tamponade, aortic dissection), lack of echogenicity or bandages covering the TTE area, pregnancy, patient’s refusal to participate.

In patients eligible for inclusion, TTE was performed to assess preload-dependency, a standard care procedure for patients with ACF at our ICU. The features (age, sex, weight, height, reason for admission), cardiovascular co-morbidities, sepsis related organ failure assessment (SOFA) score, simplified acute physiology score (SAPS) II, and serum lactate concentrations were recorded for each patient after enrollment. Systolic, diastolic and mean arterial pressures and heart rate were recorded at each time point. The inclusion time was the duration of the echocardiographic assessment at the patient’s bedside (approximatively 10 min). Each patient had an inclusion number, used to register loops and echocardiographic features anonymously in the ultrasound machine. Patients were screened and included successively, whenever an echocardiography-board certified clinician (CR, GD, LZ) was available to enroll the patient and perform TTEs according to the protocol described below.

Time-point schedule

First TTE (T0) was performed in patients at a semi-recumbent position of 45° (Fig 1). Echocardiographic measurements with LVOT-VTI assessments and 4-chambers loops were recorded. Then, a PLR was performed, and the clinician recorded a second LVTO-VTI (T1) within 60 seconds after the beginning of PLR [13]. The patients were classified in the “preload-dependent” group (PLD+) if the LVOT-VTI variations after PLR exceeded 10% [12]. Otherwise, they were classified into the “preload-independent” group (PLD-).

Fig 1. Time-point schedule and echocardiography protocol.

Fig 1

TTE: trans-thoracic echocardiography; VTI: velocity time integral; PLR: passive leg raising.

Echocardiography protocol

TTEs were performed by echocardiography-board certified clinicians (CR, GD, LZ) [35] using a General Electric (GE) Vivid IQ machine (GE HealthCare, Chicago, Illinois, USA) and a 3.5-Hz probe. The conventional evaluation was performed following the American Society of Echocardiography Recommendations [36]. A cross-sectional area of the aortic anulus was calculated from its diameter during early systole, measured in a parasternal long-axis view. The other variables were collected using an apical 4 or 5-chamber view. The ejection fraction was estimated visually by the operators [37] who also checked if the RV/LV ratio was < 1 and right ventricle had an homogeneous and normal kinetics. Echogenicity was judged as poor, moderate or good according to the ability of the clinician to either see LV with no access to RV, see LV and access to RV on another view or have a perfect visualization of the four myocardial cavities within the same view.

At each time point (T0 and T1), LVOT-VTI was measured using pulse-wave Doppler from an apical 5-chamber view. Each reported measurement of LVOT-VTI was an average of three to five consecutive measurements over one respiratory cycle. Mitral flow was assessed using an apical 4-chamber view with pulse-wave Doppler allowing for the measurement of the E and A wave velocities and the E/A ratio.

Using tissue Doppler imaging via an apical 4-chamber view, the velocity of the lateral mitral annulus E′ wave and the E/E′ lateral ratio were calculated. At the end of each time-point, a 4-chamber 7-cycles loop was registered in DICOM format with a frame rate above 50/second, for further longitudinal strain assessment. Considering the transient effect of PLR to eventually modify load conditions during T1, the operator rapidly stored loops and doppler images, and made the measurements afterwards. The whole echocardiography evaluation was assessed by the same operator for each patient. The strain analysis was conducted off-line on a decentralized computer, via the EchoPac clinical workstation software version 202 (GE Healthcare, Chicago, Illinois, USA) by level 2 (CR) and level 3 (LZ) operators [38] trained in 2D-strain echocardiography. Each anonymized TTE loop was analyzed by an operator blinded to the patient’s group (PLD+ or PLD-).

The operator traced the LV myocardial contour using the semi-automatized method of speckle tracking after identification of the baso-septal, baso-lateral and apical points [39] and adjusted the contouring manually if necessary after the visualization of the tracking on dynamic loops. LV-LS was calculated three times and averaged for each time-point loop. Intra-observer reproducibility was calculated from these data. Fifteen loops were randomly selected for a double LV-LS analyze by two clinicians (CR, LZ) to calculate the inter-observer reproducibility. To make our analysis relevant for clinical practice and due to the good correlation between the global longitudinal strain (GLS) value calculated from the averaged 2, 3 and 4-chamber views or from a 4-chamber view alone [21], longitudinal strain (LS) was estimated from the six LV segments of the apical 4-chamber loop only. The systolic strain rate (SSR) was also calculated for each loop. Its value was the most negative value of the strain rate curve occurring after the opening of the aortic valve. We also assessed right ventricle longitudinal strain (RV-LS) in the 4-chamber loops allowing for a good visualization of the entire myocardial wall. We performed an averaged measurement of strain values for the three segments of the RV lateral wall obtained through the 4-chamber view. Left atrial (LA) longitudinal strain was also analyzed following a standardized method when the registered loops allowed a good visualization of LA [40].

Statistical analysis

Data analysis was performed using R-Project for Statistical Computing 2.14 (The R Foundation, Vienna, Austria). Categorical variables were expressed as numbers and percentages (%) and continuous variables were expressed as mean ± standard deviation (SD). For each patient, VTI variations or strain variations were defined by (Value at T1 –Value at T0) / Value at T0. Statistical analysis consisted of a univariate and a bivariate analysis comparing the PLD+ and PLD- groups. Continuous variables were compared using a Kruskal-Wallis test. A p value < 0.05 was considered significant. A general linear model for repeated measures was used to compare LV-LS variations (between T0 and T1) between the two groups. In this model, PLD status (+ or -) was the predictor and LV-LS was the outcome. We assumed these LV-LS variations would be a valuable clinical tool if the area under the curve (AUC) was above 0.85 with a 95% confidence interval (CI) from 0.75 to 0.95. For this purpose, 60 patients had to be included.

The intra-observer reproducibility of LV-LS measurements was calculated from LV-LS values at T0 measured 3 times on the same loops by the same operator, on 15 patients. The mean difference was calculated and divided by the mean of the three values. The inter-observer reproducibility was calculated after LV-LS was measured three times and averaged on the same T0 loop in 15 patients by two clinicians (CR, LZ). Again, the mean difference was calculated and divided by the mean of the two clinicians mean value. Standard deviation was obtained from the three consecutive measurements of LV-LS on T0 loop for each patient, and the corresponding coefficient of variation (CV) was calculated as CV = SD/mean of the three measurements.

Results and discussion

During the study period, 109 patients met the inclusion criteria but 49/109 (44%) also met the exclusion criteria, notably poor echogenicity or no TTE window (n = 17, 35%), arrythmia (n = 8, 16%) and prohibited PLR (n = 8, 16%). From June 2018 to August 2019, 60 patients, 33 in the PLD+ group and 27 in the PLD- group, were prospectively included (Fig 2).

Fig 2. Flow chart.

Fig 2

PLR: passive leg raising maneuver, RV: right ventricle, LV: left ventricle, TTE: trans-thoracic echocardiography.

Characteristics of patients

At baseline, the patients’ characteristics were similar for all features except for vasopressors administration (more frequent in the PLD- group) and shock aetiology. Septic shock was found for 10 (30%) patients in the PLD+ group and 16 (59%) patients in the PLD- group (p = 0.03). In contrast, hemorrhagic shock was reported in 10 (30%) patients in the PLD+ group versus 2 (7%) in the PLD- group (p = 0.04) (Table 1).

Table 1. Patient characteristics at baseline.

All n = 60 PLD+ (n = 33) PLD- (n = 27) p
Sex F/M 25/35 10/23 15/12 0.08
Age (years) 58.1 ± 16.8 54.7 ± 19.7 62.2 ± 11.4 0.09
Mechanical ventilation [n (%)] 34 (56%) 17 (51%) 17 (63%) 1
PEEP (mmHg) 6.0 ± 2.0 6.1 ± 2.2 6.2 ± 2.2 0.94
ARDS [n (%)] 13 (22%) 6 (18%) 7 (26%) 0.68
RASS score -2 ± 2 -2 ± 3 -2 ± 2 0.85
Vasopressor infusion [n (%)] 44 (73%) 20 (60%) 24 (80%) 0.03
Norepinephrine infusion (mg/h) 1.0 ± 1.5 1.0 ± 1.8 1.1 ± 1.2 0.07
Lactate at t0 (mmol/l) 2.7 ± 2.5 2.7 ± 2.7 2.7 ± 2.2 0.74
SOFA score 7.8 ± 3.6 7.9 ±3.9 7.8 ±3.2 0.98
SAPS II score 47.8 ± 18.6 49.8 ± 17.9 45.3 ±19.4 0.37
Cardiovascular comorbidities [n (%)]
 Arterial hypertension 15 (25%) 7 (21%) 8 (29%) 0.65
 Coronary artery disease 3 (5.0%) 2 (6%) 1 (3%) 1
 Valvular disease 5 (6.7%) 3 (9%) 1 (3%) 0.75
 Stroke 2 (3.3%) 0 2 (7%) 0.38
Shock aetiology [n (%)]
 Sepsis 26 (45%) 10 (30%) 16 (59%) 0.03
 Vasoplegia without sepsis 7 (12%) 1 (3%) 6 (22%) 0.02
 Acute haemorrhage 12 (20%) 10 (30%) 2 (7%) 0.04
 Hypovolemia 14 (23%) 11 (33%) 3 (11%) 0.06
 Cardiogenic 1 (1.7%) 1 (3%) 0 1
Multiple trauma patient [n (%)] 21 (35%) 16 (48%) 5 (18%) 0.03
Associated organ failure [n (%)]
 Neurological 32 (53%) 19 (57%) 13 (48%) 0.64
 Respiratory 32 (53%) 15 (45%) 17 (63%) 0.27
 Kidney 12 (20%) 5 (15%) 7 (26%) 0.47
 Coagulation 14 (23%) 7 (21%) 7 (26%) 0.90
 Liver 6 (10%) 2 (6%) 4 (7%) 0.49

Data are expressed as numbers and rate or as mean ± SD. PLD+: preload-dependent, PLD-: preload-independent, PEEP: positive end-expiratory pressure, ARDS: acute respiratory distress syndrome, RASS: Richmond Agitation-Sedation scale, SOFA: Sepsis-related Organ Failure Assessment, SAPSII: simplified acute physiology score.

The clinical and biological variables were similar, apart from the initial heart rate, which was higher in the PLD+ group than in the PLD- group (Table 2).

Table 2. Clinical and echocardiographic data before (T0) and during (T1) the passive leg raising maneuver.

PLD+ (t0) n = 33 PLD- (t0) n = 27 p (t0) PLD+ (t1) n = 33 PLD- (t1) n = 27 p (t1)
Echogenicity 0.88
 Poor (n =) 3 3
 Moderate (n =) 15 17
 Good (n =) 9 13
Heart rate (b/min) 97 ± 21 83 ± 18 <0.01 95 ± 21 82 ± 17 <0.01
SAP (mmHg) 100 ± 19 108 ± 18 0.16 110 ± 22 112 ± 21 0.60
DAP (mmHg) 54 ± 13 54 ± 11 0.87 58 ± 12 56 ± 11 0.52
MAP (mmHg) 67 ± 12 71 ± 12 0.19 74 ± 14 72 ± 19 0.87
LVOT diam (mm) 20 ± 2.0 19 ± 2.0 0.14
LVOT VTI (cm) 16.8 ± 5.0 20.6 ± 4.2 <0.01 20.1 ± 6.0 20.4 ± 4.0 0.35
CO (L/min) 5.0 ± 1.7 4.8 ± 1.2 0.85 5.9 ± 1.8 4.9 ± 1.3 0.03
CI (L/min/m2) 2.8 ± 1.0 2.7 ± 0.7 0.85 3.3 ± 1.1 2.8 ± 0.7 0.11
LVEF (%) 59 ± 11 54 ± 11 0.08
S lateral (cm/s) 11.7 ± 3.9 10.4 ± 2.7 0.34 11.1 ± 3.3 9.8 ± 2.3 0.23
E’ lat (m/s) 0.1 ± 0.0 0.1 ± 0.0 0.86 0.1 ± 0.0 0.1± 0.1 0.70
E/A 1.0 ± 0.3 1.0 ± 0.3 0.67 1.0 ± 0.4 1.0 ± 0.3 0.99
E/E’ lat 7.4 ± 2.6 7.7 ± 2.9 0.79 7.0 ± 2.3 7.3 ± 3 0.99
IVC Variation (%) 26 ± 2.0 30 ± 2.0 0.53
LV–LS (%) -11.3 ± 4.2 -13.0 ± 4.2 0.12 -13.3 ± 5.2 -13.8 ± 4.1 0.51
LV–SSR (s-1) -0.9 ± 3.0 -0.9 ± 4.0 0.67 -1.0 ± 0.4 -0.9 ± 0.3 0.65
RV–LS (%) -14.7 ± 5.8 -14.4 ± 5.0 0.80 -16.4 ± 6.6 -12.3 ± 5.8 0.09
LA–LS (%) 18.2 ± 7.0 15.0 ± 6.0 0.23 16.7 ± 6.6 14.4 ± 5.6 0.28

Data are expressed as mean ± SD. p(t0) is p value for comparison of means between PLD+ and PLD- group at T0, p(t1) is p value for comparison of means between PLD+ and PLD- group at T1. SAP: systolic arterial pressure, DAP: diastolic arterial pressure, MAP: mean arterial pressure, LVOT: left ventricle outflow track, VTI: velocity time integral, CO: cardiac output, CI: cardiac index, LVEF: left ventricle ejection fraction, S lateral: peak systolic wave in tissue doppler at the lateral mitral annulus, E’ lat: peak early diastolic lateral mitral annulus velocity, E: peak early diastolic transmittal flow velocity, E/A ratio of E to A, E/E’lat ratio of E to E′lat, IVC: inferior vena cava, LV-LS: left ventricular longitudinal strain, LV-SSR: left ventricular systolic strain rate, RV-LS: right ventricular longitudinal strain, LA-LS: left atrial longitudinal strain.

Echocardiographic data

At T0, the LVOT-VTI values were lower in the PLD+ group than in the PLD- group (16.8 cm (± 5.0) versus 20.6 cm (± 4.2), p< 0.01) whereas heart rate was significantly higher in the PLD+ group than in the PLD- group, resulting in a similar cardiac output. The other echocardiographic data at T0 were similar between the two groups. Mean baseline LV-LS was -11.3% (± 4.2) in the PLD+ group and -13.0% (± 4.2) in the PLD- group (p = 0.12) (Table 2).

Regarding variations after PLR, mean LVOT-VTI variations (T0-T1) were +21% (±8) in the PLD+ group and -1% (±7) in the PLD- group (p< 0.01). Mean LV-LS variations between T0 and T1 in the whole population were +16% (±4) (p = 0.04). In the PLD+ group, mean LV-LS variations between T0 and T1 were +19% (±31) (p = 0.05) whereas in the PLD- group, LV-LS variations were +11% (±38) (p = 0.25). These variations of LV-LS after PLR were not statistically different between the groups (p = 0.08) (Fig 3).

Fig 3. Variations of mean LV-LS after a passive leg raising.

Fig 3

+ 11% (±38%) in the PLD- group versus + 19% (±31%) in the PLD+, p = 0.08 (Kruskal-Wallis test). Dark line represents the median for each group.

Using a linear model for repeated measures, LV-LS variations after PLR were not different between the two groups (p = 0.13) (Fig 4). There was no significant difference neither after adjusting the model on two possible confounding factors, septic shock and norepinephrine infusion.

Fig 4. Compared LV-LS variations in-between baseline and PLR, in PLD+ patients versus PLD- patients, using a linear model for repeated measures, p = 0.13.

Fig 4

The AUC for the LV-LS variations between T0 and T1 was 0.63 [0.48–0.77], which suggests that the variations in LV-LS after PLR do not predict fluid responsiveness in patients with ACF (Fig 5).

Fig 5. Receiver operating curve for evaluation of LV-LS variations during PLR to predict fluid responsiveness.

Fig 5

AUC: area under curve.

Right ventricular longitudinal strain was assessed in 27 patients (16 from the PLD+ group and 11 from the PLD- group) showing no difference between baseline and T1 in the whole population (RV-LS at T0 was -14.6 (±5.38) and at T1–14.7 (±6.55), p = 0.94). There was no difference between the two groups at T0: mean RV-LS was -14.7% (±5.8) in the PLD+ group and -14.4% (±5.0) in the PLD- group (p = 0.80). The RV-LS variations after PLR were +10% (±45%) in the PLD+ group and +5% (±61%) in the PLD- group (p = 0.69).

At baseline, mean SSR in the whole population (n = 60) was -0.90 (±0.36) and did not vary after PLR; -0.96 (±0.35), p = 0.37. SSR was similar in the 2 groups (PLD+ -0.90s-1 (±3); PLD- −0.90s-1 (±4); p = 0.67) and did not vary after PLR in either of the groups.

Baseline mean left-atrial longitudinal strain (LA-LS) was 16.69 (±6.51) in the whole population (available evaluation for 31 patients) and did not vary after PLR; 15.64 (±6.17), p = 0.41. Neither did this variable vary after PLR between the two groups.

Intra-observer variability was 6.6% (±4.6) (CR level 2 operator) and 8.3% (±6.2) (LZ level 3 operator). Coefficient of variation was 5.3% (±3.7) for CR and was 5.2% (±5.1) for LZ. Inter-observer variability (calculated with means of three measurements performed by each observer) was 4.4% (±3.1) and coefficient of variation was 2.2% (±1.6).

Discussion

To our knowledge, this is the first study evaluating the performance of LV-LS variations to predict fluid responsiveness in ICU patients. Our results confirm previous findings showing that LV-LS is preload-dependent, as LV-LS value increased significantly in the whole population and in the PLD+ subgroup after a PLR maneuver. However, in our cohort, LV-LS variations during PLR were not a discriminating marker to assess preload-dependency and predict fluid responsiveness in clinical practice.

In their study, Nafati et al. showed that absolute LV-LS values at baseline were altered in a preload-dependent population of ICU patients [21]. Our study confirms these results, with a decreased baseline LV-LS in our entire population. Mean LV-LS was worst in the PLD+ group but increased in both groups after PLR (+19% in the PLD+ group p = 0.05; +11% in the PLD- group p = 0.25), which made it difficult to ascertain a significant difference in LV-LS augmentation between the two groups. These LV-LS variations appeared to be mainly related to the increase in the end-diastolic stretch of the myocardial fibers (L0) after correcting preload via PLR, as shown previously, but this stretching response can also depend on the aetiology of ACF.

The studied population in this cohort is representative of patients admitted to ICUs with ACF, with varied pathologies leading to circulatory failure such as sepsis, haemorrhage, major surgery responsible for a systemic inflammatory response. We chose to enroll patients admitted for any cause of ACF, which led to a great heterogenicity in our population, regarding clinical features and the pathophysiological mechanism responsible for a circulatory failure. Our final groups, PLD+ and PLD-, were not akin regarding the aetiology of ACF.

As a matter of fact, there were significantly more patients admitted for septic shock in the PLD- than in the PLD+ group, which possibly biased our analysis. Boissier et al. showed that patients with septic shock could be either hyperkinetic with improved LV-LS values or normokinetic or hypokinetic with lower LV-LS values [41]. They explained these results through the various incidences of myocardial dysfunction in septic shock patients and the heterogeneity of afterload conditions, but they assessed LV-LS without an accurate evaluation of preload (i.e. through LV filling pressure, vena cava variation, end-diastolic and systolic volume estimation). Ng et al. compared a group of patients with septic shock with a control group of septic patients without shock [42]. Again, there were significant differences in LV-LS, but no accurate evaluation of preload-dependency was performed. To date, it has not been possible to assert that septic shock is responsible for an alteration in LV-LS that is independent of load conditions. Nevertheless, septic shock induces changes in both preload and afterload, which interact with inotropism. The resulting LV dysfunction is typically associated with non-elevated filling pressures and increased LV compliance [43, 44]. These pathophysiological changes in LV function in septic patients affect LV-LS. In our study, the septic population was too small to conduct relevant subgroup analysis, but this repartition of septic patients could have influenced our findings. Moreover, statistical analysis revealed a wide spread of data, making it difficult to conclude to significant differences and to define a threshold for clinical use.

We must also acknowledge a lack of statistical power to ascertain a correlation between LV-LS variations and preload even in the “hypovolemia” subgroup, due to a small number of patients. We basically calculated the number of required subjects according to our primary goal, which was to determine the sensitivity and specificity of LV-LS variations to assess preload-dependency with an area under the curve of at least 0.85. We could not anticipate how LV-LS would vary in our cohort and in what proportion. The a posteriori calculated required number of subject to ascertain a statistical difference in LV-LS variation between the groups explains a lack of power in our study.

Data for RV-LS was only available for 27 patients (16 PLD+ and 11 PLD-) at both T0 and T1. Regarding the RV, our results suggest a tendency for an increased RV-LS in the PLD+ group whereas RV-LS decreased in the PLD- group after PLR. Our findings are limited due to a low number of patients; however, they do foster the launch of future studies.

Systolic strain rate (SSR) was also measured at each time-point. We found no differences in SSR between the two groups and no variations after PLR. Fredholm et al. found that SSR depends on both preload and heart rate and found an increase after PLR. However, they performed strain measurements via transesophageal echocardiography during cardiac surgery with cardiopulmonary bypass, which involves very different loading conditions than those met in our ICU patients [45].

Regarding the usual echocardiographic markers that were evaluated at T0 and T1, there was a significant difference concerning cardiac output (and surrogates as LVOT-VTI) between the PLD+ and PLD-, but no significant difference was observed concerning echocardiographic markers of left-ventricular end diastolic pressure (LVEDP). Indeed, there was no difference between mean E, E’ lat, nor E/E’lat between PLD+ and PLD- and no significant variation of these markers between T0 and T1 in the whole population. Yet, some authors showed a relationship between E’lat and preload. Mahjoub et al. [46] showed a significant increase of E’lat (and a resultant decrease in E/E’lat) in a population of septic shock patients with diastolic dysfunction (E’Lat < 0.12cm/s) receiving a 500 ml crystalloid administration. These results suggest an improvement of LV relaxation with the correction of hypovolemia in patients with septic shock and diastolic dysfunction. Lamia et al. [14] studied the variations of echocardiographic markers of preload and LVEDP using a PLR maneuver, followed by a volume expansion and found similar results as ours, i.e. a non-significant variation of E, E’Lat and E/E’lat between responders and non-responders following PLR or crystalloid infusion. This study also concerned patients with various aetiology responsible for circulatory failure. Thus, if an increase of E’lat can be observed in preload-dependent patients after correcting hypovolemia, E/E’lat variation is not very accurate to quantify small transitory variations of preload and should rather be used as a marker of LVED, to anticipate the risk of fluid overload when a volume expansion is considered to treat ACF.

Our study has some other limitations we must acknowledge. Left-ventricular longitudinal strain was assessed using a 4-chamber echocardiographic view alone. The accurate assessment of GLS involves performing a 2-chamber, 3-chamber and 4-chamber view to average the values of all 17 LV myocardial segments. In clinical practice, this reference method is probably too complicated to assess fluid responsiveness. Furthermore, a recent study showed that LV global longitudinal strain calculated from averaged 2-3-4-chamber views had a strong correlation with LV longitudinal strain calculated from a 4-chamber view alone [21]. By extension, we considered LV-LS the LV longitudinal strain we obtained from a 4-chamber view.

We chose VTI variations after PLR as a reference method, with a 10% threshold to classify our patients into either the PDL or in the PLD- group. This threshold was acknowledged to accurately predict fluid responsiveness in ACF patients in most situations [12], including spontaneous breathing, atrial fibrillation and pregnancy [5, 47]. Yet, other authors like Roger et al. have used a higher threshold of 15% VTI variation to predict fluid responsiveness [48]. For that purpose, they performed a fluid infusion with 500 ml of crystalloids for every patient with ACF. They showed that preload-dependency is a labile parameter, with patients qualified as transient responders to FR 10 minutes after FR, becoming non-responders only 20 minutes after the end of FR. In our study, we used a non-invasive method to assess fluid responsiveness (i.e PLR), instead of administrating fluid on clinical criteria of ACF with a 50% risk of inappropriate FR. Our lower threshold might have misclassified patients into the PLD+ group.

Monnet et al. reviewed the performance of PLR in predicting fluid responsiveness in a meta-analysis. They showed that direct evaluation of CO variations (or surrogate like VTI variations) was the most accurate way to assess preload-dependency [12]. However, the evaluation of preload-dependency with PLR could be inaccurate if intra-abdominal pressure is above 12 cmH2O. In our study, intra-abdominal pressure was not measured before inclusion, which could involve a possible classification bias in our patients [49]. Moreover, a study showed that, even when performed by the same operator, the least significant changes in the VTI assessments were 11%, suggesting the use of higher thresholds for VTI changes to predict fluid responsiveness [47].

Conclusion

Our study showed that LV-LS variations after PLR do not predict fluid responsiveness.

Our results confirm that LV-LS is preload-dependent, but its value might also be influenced by afterload and intrinsic myocardial function, which varies with the aetiology of ACF. The heterogeneity of ACF causes in our cohort made it tenuous to draw conclusions about using speckle tracking strain variations as a useful tool to predict fluid-responsiveness or tolerance to fluid administration. An assessment of the relationship between LV-LS variations and preload in a more homogenous population of ICU patients might thus be of interest and requires further evaluation.

Data Availability

The data file is held in the Open Science Framework repository at https://osf.io/e6tm4/.

Funding Statement

The authors received no specific funding for this work.

References

  • 1.Constantin JM, Leone M, Jaber S, Allaouchiche B, Orban JC, Cannesson M, et al. [Activity and the available human resources working in 66 French Southern intensive care units]. Ann Fr Anesth Reanim. 2010;29: 512–517. [DOI] [PubMed] [Google Scholar]
  • 2.Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med. 2017;43: 304–377. doi: 10.1007/s00134-017-4683-6 [DOI] [PubMed] [Google Scholar]
  • 3.Cecconi M, Hernandez G, Dunser M, Antonelli M, Baker T, Bakker J, et al. Fluid administration for acute circulatory dysfunction using basic monitoring: narrative review and expert panel recommendations from an ESICM task force. Intensive Care Med. 2019;45: 21–32. doi: 10.1007/s00134-018-5415-2 [DOI] [PubMed] [Google Scholar]
  • 4.Michard F, Teboul J-L. Predicting fluid responsiveness in ICU patients: a critical analysis of the evidence. Chest. 2002;121: 2000–2008. doi: 10.1378/chest.121.6.2000 [DOI] [PubMed] [Google Scholar]
  • 5.Brun C, Zieleskiewicz L, Textoris J, Muller L, Bellefleur J-P, Antonini F, et al. Prediction of fluid responsiveness in severe preeclamptic patients with oliguria. Intensive Care Med. 2013;39: 593–600. doi: 10.1007/s00134-012-2770-2 [DOI] [PubMed] [Google Scholar]
  • 6.Boyd JH, Forbes J, Nakada T, Walley KR, Russell JA. Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med. 2011;39: 259–265. doi: 10.1097/CCM.0b013e3181feeb15 [DOI] [PubMed] [Google Scholar]
  • 7.Acheampong A, Vincent J-L. A positive fluid balance is an independent prognostic factor in patients with sepsis. Crit Care Lond Engl. 2015;19: 251. doi: 10.1186/s13054-015-0970-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Jozwiak M, Silva S, Persichini R, Anguel N, Osman D, Richard C, et al. Extravascular lung water is an independent prognostic factor in patients with acute respiratory distress syndrome. Crit Care Med. 2013;41: 472–480. doi: 10.1097/CCM.0b013e31826ab377 [DOI] [PubMed] [Google Scholar]
  • 9.Kirkpatrick AW, Roberts DJ, De Waele J, Jaeschke R, Malbrain MLNG, De Keulenaer B, et al. Intra-abdominal hypertension and the abdominal compartment syndrome: updated consensus definitions and clinical practice guidelines from the World Society of the Abdominal Compartment Syndrome. Intensive Care Med. 2013;39: 1190–1206. doi: 10.1007/s00134-013-2906-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Payen D, de Pont AC, Sakr Y, Spies C, Reinhart K, Vincent JL, et al. A positive fluid balance is associated with a worse outcome in patients with acute renal failure. Crit Care Lond Engl. 2008;12: R74. doi: 10.1186/cc6916 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Monnet X, Marik PE, Teboul J-L. Prediction of fluid responsiveness: an update. Ann Intensive Care. 2016;6: 111. doi: 10.1186/s13613-016-0216-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Monnet X, Marik P, Teboul J-L. Passive leg raising for predicting fluid responsiveness: a systematic review and meta-analysis. Intensive Care Med. 2016;42: 1935–1947. doi: 10.1007/s00134-015-4134-1 [DOI] [PubMed] [Google Scholar]
  • 13.Monnet X, Rienzo M, Osman D, Anguel N, Richard C, Pinsky MR, et al. Passive leg raising predicts fluid responsiveness in the critically ill. Crit Care Med. 2006;34: 1402–1407. doi: 10.1097/01.CCM.0000215453.11735.06 [DOI] [PubMed] [Google Scholar]
  • 14.Lamia B, Ochagavia A, Monnet X, Chemla D, Richard C, Teboul J-L. Echocardiographic prediction of volume responsiveness in critically ill patients with spontaneously breathing activity. Intensive Care Med. 2007;33: 1125–1132. doi: 10.1007/s00134-007-0646-7 [DOI] [PubMed] [Google Scholar]
  • 15.Cherpanath TGV, Hirsch A, Geerts BF, Lagrand WK, Leeflang MM, Schultz MJ, et al. Predicting Fluid Responsiveness by Passive Leg Raising: A Systematic Review and Meta-Analysis of 23 Clinical Trials. Crit Care Med. 2016;44: 981–991. doi: 10.1097/CCM.0000000000001556 [DOI] [PubMed] [Google Scholar]
  • 16.Oren-Grinberg A, Park KW. Assessment of myocardial systolic function by TEE. Int Anesthesiol Clin. 2008;46: 31–49. doi: 10.1097/AIA.0b013e31811f45e7 [DOI] [PubMed] [Google Scholar]
  • 17.Gaillard E, Kadem L, Clavel M-A, Pibarot P, Durand L-G. Optimization of Doppler echocardiographic velocity measurements using an automatic contour detection method. Ultrasound Med Biol. 2010;36: 1513–1524. doi: 10.1016/j.ultrasmedbio.2010.05.021 [DOI] [PubMed] [Google Scholar]
  • 18.Muller L, Toumi M, Bousquet P-J, Riu-Poulenc B, Louart G, Candela D, et al. An increase in aortic blood flow after an infusion of 100 ml colloid over 1 minute can predict fluid responsiveness: the mini-fluid challenge study. Anesthesiology. 2011;115: 541–547. doi: 10.1097/ALN.0b013e318229a500 [DOI] [PubMed] [Google Scholar]
  • 19.Marwick TH, Shah SJ, Thomas JD. Myocardial Strain in the Assessment of Patients With Heart Failure: A Review. JAMA Cardiol. 2019. doi: 10.1001/jamacardio.2019.0052 [DOI] [PubMed] [Google Scholar]
  • 20.Urheim S, Edvardsen T, Torp H, Angelsen B, Smiseth OA. Myocardial strain by Doppler echocardiography. Validation of a new method to quantify regional myocardial function. Circulation. 2000;102: 1158–1164. doi: 10.1161/01.cir.102.10.1158 [DOI] [PubMed] [Google Scholar]
  • 21.Nafati C, Gardette M, Leone M, Reydellet L, Blasco V, Lannelongue A, et al. Use of speckle-tracking strain in preload-dependent patients, need for cautious interpretation! Ann Intensive Care. 2018;8: 29. doi: 10.1186/s13613-018-0376-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Nafati C, Lançon V, Blasco V, Zieleskiewicz L, Harti K, Wiramus S, et al. Two-dimensional-strain echocardiography in intensive care unit patients: A prospective, observational study. J Clin Ultrasound JCU. 2016;44: 368–374. doi: 10.1002/jcu.22349 [DOI] [PubMed] [Google Scholar]
  • 23.Cinotti R, Delater A, Fortuit C, Roquilly A, Mahé P-J, Demeure-dit-Latte D, et al. Speckle-Tracking analysis of left ventricular systolic function in the intensive care unit. Anaesthesiol Intensive Ther. 2015;47: 482–486. doi: 10.5603/AIT.a2015.0078 [DOI] [PubMed] [Google Scholar]
  • 24.Chang W-T, Lee W-H, Lee W-T, Chen P-S, Su Y-R, Liu P-Y, et al. Left ventricular global longitudinal strain is independently associated with mortality in septic shock patients. Intensive Care Med. 2015;41: 1791–1799. doi: 10.1007/s00134-015-3970-3 [DOI] [PubMed] [Google Scholar]
  • 25.Voigt J-U, Pedrizzetti G, Lysyansky P, Marwick TH, Houle H, Baumann R, et al. Definitions for a common standard for 2D speckle tracking echocardiography: consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imaging. Eur Heart J—Cardiovasc Imaging. 2015;16: 1–11. doi: 10.1093/ehjci/jeu184 [DOI] [PubMed] [Google Scholar]
  • 26.Negishi T, Negishi K, Thavendiranathan P, Cho G-Y, Popescu BA, Vinereanu D, et al. Effect of Experience and Training on the Concordance and Precision of Strain Measurements. JACC Cardiovasc Imaging. 2017;10: 518–522. doi: 10.1016/j.jcmg.2016.06.012 [DOI] [PubMed] [Google Scholar]
  • 27.Yingchoncharoen T, Agarwal S, Popović ZB, Marwick TH. Normal ranges of left ventricular strain: a meta-analysis. J Am Soc Echocardiogr Off Publ Am Soc Echocardiogr. 2013;26: 185–191. doi: 10.1016/j.echo.2012.10.008 [DOI] [PubMed] [Google Scholar]
  • 28.Liu Y-W, Tsai W-C, Su C-T, Lin C-C, Chen J-H. Evidence of left ventricular systolic dysfunction detected by automated function imaging in patients with heart failure and preserved left ventricular ejection fraction. J Card Fail. 2009;15: 782–789. doi: 10.1016/j.cardfail.2009.05.006 [DOI] [PubMed] [Google Scholar]
  • 29.Negishi K, Borowski AG, Popović ZB, Greenberg NL, Martin DS, Bungo MW, et al. Effect of Gravitational Gradients on Cardiac Filling and Performance. J Am Soc Echocardiogr Off Publ Am Soc Echocardiogr. 2017;30: 1180–1188. doi: 10.1016/j.echo.2017.08.005 [DOI] [PubMed] [Google Scholar]
  • 30.Weber U, Base E, Ristl R, Mora B. Effect of Preload Alterations on Left Ventricular Systolic Parameters Including Speckle-Tracking Echocardiography Radial Strain During General Anesthesia. J Cardiothorac Vasc Anesth. 2015;29: 852–859. doi: 10.1053/j.jvca.2014.12.015 [DOI] [PubMed] [Google Scholar]
  • 31.Burns AT, La Gerche A, D’hooge J, MacIsaac AI, Prior DL. Left ventricular strain and strain rate: characterization of the effect of load in human subjects. Eur J Echocardiogr J Work Group Echocardiogr Eur Soc Cardiol. 2010;11: 283–289. doi: 10.1093/ejechocard/jep214 [DOI] [PubMed] [Google Scholar]
  • 32.Dahle GO, Stangeland L, Moen CA, Salminen P-R, Haaverstad R, Matre K, et al. The influence of acute unloading on left ventricular strain and strain rate by speckle tracking echocardiography in a porcine model. Am J Physiol Heart Circ Physiol. 2016;310: H1330–1339. doi: 10.1152/ajpheart.00947.2015 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Choi J-O, Shin D-H, Cho SW, Song YB, Kim JH, Kim YG, et al. Effect of preload on left ventricular longitudinal strain by 2D speckle tracking. Echocardiogr Mt Kisco N. 2008;25: 873–879. doi: 10.1111/j.1540-8175.2008.00707.x [DOI] [PubMed] [Google Scholar]
  • 34.Toulouse E, Masseguin C, Lafont B, McGurk G, Harbonn A, A Roberts J, et al. French legal approach to clinical research. Anaesth Crit Care Pain Med. 2018;37: 607–614. doi: 10.1016/j.accpm.2018.10.013 [DOI] [PubMed] [Google Scholar]
  • 35.Expert Round Table on Echocardiography in ICU. International consensus statement on training standards for advanced critical care echocardiography. Intensive Care Med. 2014;40: 654–666. doi: 10.1007/s00134-014-3228-5 [DOI] [PubMed] [Google Scholar]
  • 36.Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr Off Publ Am Soc Echocardiogr. 2015;28: 1–39.e14. doi: 10.1016/j.echo.2014.10.003 [DOI] [PubMed] [Google Scholar]
  • 37.Lavine SJ, Salacata A. Visual quantitative estimation: semiquantitative wall motion scoring and determination of ejection fraction. Echocardiogr Mt Kisco N. 2003;20: 401–410. doi: 10.1046/j.1540-8175.2003.03079.x [DOI] [PubMed] [Google Scholar]
  • 38.Mayo PH, Beaulieu Y, Doelken P, Feller-Kopman D, Harrod C, Kaplan A, et al. American College of Chest Physicians/La Société de Réanimation de Langue Française statement on competence in critical care ultrasonography. Chest. 2009;135: 1050–1060. doi: 10.1378/chest.08-2305 [DOI] [PubMed] [Google Scholar]
  • 39.Mondillo S, Galderisi M, Mele D, Cameli M, Lomoriello VS, Zacà V, et al. Speckle-tracking echocardiography: a new technique for assessing myocardial function. J Ultrasound Med Off J Am Inst Ultrasound Med. 2011;30: 71–83. doi: 10.7863/jum.2011.30.1.71 [DOI] [PubMed] [Google Scholar]
  • 40.Badano LP, Kolias TJ, Muraru D, Abraham TP, Aurigemma G, Edvardsen T, et al. Standardization of left atrial, right ventricular, and right atrial deformation imaging using two-dimensional speckle tracking echocardiography: a consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imaging. Eur Heart J Cardiovasc Imaging. 2018;19: 591–600. doi: 10.1093/ehjci/jey042 [DOI] [PubMed] [Google Scholar]
  • 41.Boissier F, Razazi K, Seemann A, Bedet A, Thille AW, de Prost N, et al. Left ventricular systolic dysfunction during septic shock: the role of loading conditions. Intensive Care Med. 2017;43: 633–642. doi: 10.1007/s00134-017-4698-z [DOI] [PubMed] [Google Scholar]
  • 42.Ng PY, Sin WC, Ng AK-Y, Chan WM. Speckle tracking echocardiography in patients with septic shock: a case control study (SPECKSS). Crit Care Lond Engl. 2016;20: 145. doi: 10.1186/s13054-016-1327-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Parker MM, Shelhamer JH, Bacharach SL, Green MV, Natanson C, Frederick TM, et al. Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med. 1984;100: 483–490. doi: 10.7326/0003-4819-100-4-483 [DOI] [PubMed] [Google Scholar]
  • 44.Vignon P, Huang SJ. Global longitudinal strain in septic cardiomyopathy: the hidden part of the iceberg? Intensive Care Med. 2015;41: 1851–1853. doi: 10.1007/s00134-015-3962-3 [DOI] [PubMed] [Google Scholar]
  • 45.Fredholm M, Jörgensen K, Houltz E, Ricksten S-E. Load-dependence of myocardial deformation variables—a clinical strain-echocardiographic study. Acta Anaesthesiol Scand. 2017;61: 1155–1165. doi: 10.1111/aas.12954 [DOI] [PubMed] [Google Scholar]
  • 46.Mahjoub Y, Benoit-Fallet H, Airapetian N, Lorne E, Levrard M, Seydi A-A, et al. Improvement of left ventricular relaxation as assessed by tissue Doppler imaging in fluid-responsive critically ill septic patients. Intensive Care Med. 2012;38: 1461–1470. doi: 10.1007/s00134-012-2618-9 [DOI] [PubMed] [Google Scholar]
  • 47.Jozwiak M, Mercado P, Teboul J-L, Benmalek A, Gimenez J, Dépret F, et al. What is the lowest change in cardiac output that transthoracic echocardiography can detect? Crit Care Lond Engl. 2019;23: 116. doi: 10.1186/s13054-019-2413-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Roger C, Zieleskiewicz L, Demattei C, Lakhal K, Piton G, Louart B, et al. Time course of fluid responsiveness in sepsis: the fluid challenge revisiting (FCREV) study. Crit Care Lond Engl. 2019;23: 179. doi: 10.1186/s13054-019-2448-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Beurton A, Teboul J-L, Girotto V, Galarza L, Anguel N, Richard C, et al. Intra-Abdominal Hypertension Is Responsible for False Negatives to the Passive Leg Raising Test. Crit Care Med. 2019;47: e639–e647. doi: 10.1097/CCM.0000000000003808 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Robert Ehrman

24 May 2021

PONE-D-21-11995

Left ventricular longitudinal strain variations assessed by speckle-tracking echocardiography after a passive leg raising maneuver to predict fluid responsiveness: A prospective, observational, monocentric study

PLOS ONE

Dear Dr. ROY,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

This is an interesting paper that I think makes an important contribution to the literature in this area. However, there are some areas that I believe require revision and/or clarification prior to publication. In addition to the comments from the reviewers, please consider the following:

-Can you provide more detail about the repeated measures regression model? It seems like LV-LS was the outcome and PLR + vs - was the predictor--is this correct? While many of the characteristics were similar in the PLR groups, I wonder if there are any potential confounders that could be adjusted for in the model? there is probably not a "right" answer, and an overfit model is certainly not advantageous to anyone, but I think that more detail about the model itself and the decisions and assumptions that went into to would provide clarity and strength to the paper.

-Another important idea is that of patient-level heterogeneity and its relationship to PLR status and echo parameters. you have alluded to this in the conclusion section, and i certainly agree with the ideas presented therein. however, i think this is a very important part of the paper and would be more appropriately located in the discussion or limitations section, perhaps with a bit more detail/explanation.

Please submit your revised manuscript by Jul 08 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Robert Ehrman, MD, MS

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please provide additional details regarding participant consent.

In the ethics statement in the Methods and online submission information, please ensure that you have specified what type of consent you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If the need for consent was waived by the ethics committee, please include this information.

3. Thank you for stating the following in the Competing Interests section:

'Laurent Zieleskiewicz received fees from General Electrics Healthcare for ultrasound teaching'

a. Please confirm that this does not alter your adherence to all PLOS ONE policies on sharing data and materials, by including the following statement: "This does not alter our adherence to  PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests).  If there are restrictions on sharing of data and/or materials, please state these.

Please note that we cannot proceed with consideration of your article until this information has been declared.

b. Please include your updated Competing Interests statement in your cover letter; we will change the online submission form on your behalf.

Please know it is PLOS ONE policy for corresponding authors to declare, on behalf of all authors, all potential competing interests for the purposes of transparency. PLOS defines a competing interest as anything that interferes with, or could reasonably be perceived as interfering with, the full and objective presentation, peer review, editorial decision-making, or publication of research or non-research articles submitted to one of the journals. Competing interests can be financial or non-financial, professional, or personal. Competing interests can arise in relationship to an organization or another person. Please follow this link to our website for more details on competing interests: http://journals.plos.org/plosone/s/competing-interests

4. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: I thank the authors and editor for the privilege of reviewing this manuscript. In, “Left ventricular longitudinal strain variations assessed by speckle-tracking echocardiography after a passive leg raising maneuver to predict fluid responsiveness: A prospective, observational, monocentric study,” Roy and colleagues assessed left ventricular longitudinal strain as a predictor for fluid responsiveness after a passive leg raise.

Major:

1. The PLR maneuver can cause translation of the heart and affect VTI assessments. Please comment on this in the limitations

2. The study omitted one third of eligible patients due to technical limitations. This may bias the sample, as these patients might be sicker. Please comment on this in the limitations.

3. I have concerns for a type I error. E/e’ is a surrogate for preload, or more specifically LVEDP. There is no difference between PLD+ and PLD- patients at T0 for E/e’. E/e’ is a marker of preload, not preload responsiveness, so it’s not completely incorrect if there is no difference between groups. However, E/e’ decreased with the PLR in both PLD+ and PLD- patients, which would suggest inconsistency in E/e’ measurement, in PLD assessment, or both. Please clarify. Additionally, the main outcome (ΔStrain after PLR) is perhaps not the most obvious variable to select, and it barely achieves significance, while several other hypotheses were assessed. Please confirm in the methods that the delta longitudinal strain after a PLR was the a priori primary assessment, or please correct these tests of significance for multiple hypothesis testing.

Minor:

1. Page 4 and 5. VTI after PLR is perhaps the most generalizable and generally the most accurate method of assessing preload responsiveness, but it is misleading to call it the gold standard. Please revise.

2. Table 1: Sex is misspelled (Sexe)

Reviewer #2: 1.This study included patients with ACF and echocardiography was conducted at T0 and T1. In conclusion, this study confirms that LV-LS is load-dependent; however, the variations in LV-LS after PLR is not a discriminating criterion to predict fluid responsiveness of ICU patients with ACF.

2.Title: It would be better to point out the subjects (patients with ACF) included in this study in the title. Additionally, the title should indicated the conclusion that variations in LV-LS after PLR is not a discriminating criterion to predict fluid responsiveness.

3.Methods: fluid responsiveness should be defined in the Methods.

4.Results(page13, line271): This study compared the variation of LV-LS in whole subjets after PLR. The variations of other parameters after PLR such as LV-SSR, RV-LS and LA-LS which were assessed by speckle tracking analysis should be added in this analysis to test their prediction value for fluid responsiveness.

5.Results(page13, line270-274): Significant differences of mean LV-LS variations between T0 and T1 was observed in the whole population (n=60, p=0.04), but not in the PLD+ group (n=33, p=0.04) and PLD- group(n=27, p=0.25). Additionally, these variations of LV-LS after PLR were not statistically different between the groups (p=0.08). The results might result from the small numbers of subjects, and statistical power test should ba added in this study.

6.Is there any liner correlation between varations of LV RVOT VTI and LV-LS after PLR?

7.Conclusion(page18, line384-385): This study did not test the correlations between LV-LS and afterload and intrinsic myocardial function. You should add related statistical analysis or modify the conclusion.

8.What is the advantages and innovations of this study?

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Sep 30;16(9):e0257737. doi: 10.1371/journal.pone.0257737.r002

Author response to Decision Letter 0


6 Jul 2021

* Comments from academic editor :

1) Can you provide more detail about the repeated measures regression model? It seems like LV-LS was the outcome and PLR + vs - was the predictor--is this correct?

While many of the characteristics were similar in the PLR groups, I wonder if there are any potential confounders that could be adjusted for in the model? there is probably not a "right" answer, and an overfit model is certainly not advantageous to anyone, but I think that more detail about the model itself and the decisions and assumptions that went into to would provide clarity and strength to the paper Thank you for your remark. In the presented regression model for repeated measures, preload dependency status (represented by PLD+ or PLD-) was the predictor, and the myocardial strain response to PLR, evaluated by LV-LS, was the outcome.

Response : In this model, LV-LS is the dependent variable, that varies between two time points T0 and T1. PLD+ and PLD- are independent of T0 and T1. The intra-subject effect shows an increase of LV-LS absolute value, in both groups (PLD+ and PLD-) between T0 and T1 (with p = 0.001 in the regression model). But there is no inter-subject statistical difference, with p = 0.13 when we compared the two groups.

We conducted a univariate analysis which found no association between the major confounding factors (e.g aetiology of ACF, norepinephrine infusion, lactate level, sedation). The correlation matrix showed no evidence for correlation, apart for expected couples (i.e septic shock/norepinephrine infusion).

We conducted further statistical analysis as you suggested, adjusting the regression model on two variables which were close to significance in the univariate analysis with p<0.2 : septic shock and norepinephrine infusion.

When adjusting the regression model for repeated measures on septic shock we found p = 0.292, when adjusting on norepinephrine infusion we find p = 0.612.

We discussed this important point in the revised manuscript.

2) Another important idea is that of patient-level heterogeneity and its relationship to PLR status and echo parameters. You have alluded to this in the conclusion section, and I certainly agree with the ideas presented therein. however, I think this is a very important part of the paper and would be more appropriately located in the discussion or limitations section, perhaps with a bit more detail/explanation

Response : Thank you for this comment.

Changes were made in the discussion section.

“The studied population in this cohort is representative of patients admitted in ICUs with ACF, with varied pathologies leading to circulatory failure such as sepsis, haemorrhage, heavy surgery followed by systemic inflammatory response. We chose to enroll patients admitted for any cause of ACF, which led to a great heterogenicity in our population, regarding clinical features and the pathophysiological mechanism responsible for a circulatory failure. Our final groups, PLD+ and PLD-, were not akin concerning the aetiology of ACF. As matter of fact, there were significantly more patients admitted for septic shock in the PLD- than in the PLD+ group, which possibly biased our analysis.” [15]

*Comments from Reviewer #1

1) The PLR maneuver can cause translation of the heart and affect VTI assessments. Please comment on this in the limitations

Response : Thank you for this remark we for sure agree with.

However, it has been shown in a meta-analysis by Cherpanath et al. [15] that the pulse contour derived-cardiac output, as well as the cardiac output measured by esophageal Doppler, transthoracic echocardiography or bioreactance had a similar diagnostic performance to assess cardiac output variations after a passive leg raising maneuver.

Possible translation of the heart during PLR does not seem to have a negative impact on the evaluation of CO surrogates such as LVOT-VTI. Furthermore, in clinical practice, delta VTI after PLR was acknowledged a validated tool with an almost perfect area under the curve (Monnet et al. [11]) and is currently consider as a gold standard for fluid responsiveness diagnosis in large studies (Vignon et al, Comparison of Echocardiographic Indices Used to Predict Fluid Responsiveness in Ventilated Patients, AJRCCM 2017).

2) The study omitted one third of eligible patients due to technical limitations. This may bias the sample, as these patients might be sicker. Please comment on this in the limitations.

Response : Thank you for this interesting question.

Within the 49 excluded patients, 17 had poor echogenicity. Most of them were admitted after major thoracic surgery which is an important part of our ICU recruitment. Bandage, surgical wounds, leaft us poor echographic window.

However, excluded patients had a similar mean SAPSII score to included patients. Unfortunately, we did not assess SOFA score in the non-included population but severity of the patients was never the reason of their non-inclusion.

3) I have concerns for a type I error. E/e’ is a surrogate for preload, or more specifically LVEDP. There is no difference between PLD+ and PLD- patients at T0 for E/e’. E/e’ is a marker of preload, not preload responsiveness, so it’s not completely incorrect if there is no difference between groups. However, E/e’ decreased with the PLR in both PLD+ and PLD- patients, which would suggest inconsistency in E/e’ measurement, in PLD assessment, or both. Please clarify. Additionally, the main outcome (ΔStrain after PLR) is perhaps not the most obvious variable to select, and it barely achieves significance, while several other hypotheses were assessed. Please confirm in the methods that the delta longitudinal strain after a PLR was the a priori primary assessment, or please correct these tests of significance for multiple hypothesis testing. Thank you for this comment.

Response : As far as E/e’ is concerned:

We agree that E/e’ variation after PLR can be used to control PLR efficiency. However, E/e’ variation is not very accurate to quantify small transitory variations of preload. One reason might be that an increase of e’ is observed in preload dependent patients after correcting hypovolemia as shown by Mahjoub and colleagues (Mahjoub et al, Improvement of left ventricular relaxation as assessed by tissue Doppler imaging in fluid-responsive critically ill septic patients, Int Care Med, 2012).

As reviewer#1 noticed, E/e’ was more specifically validated as a marker of LV filling pressure, allowing clinicians to anticipate the risk of fluid overload when a volume expansion is considered to treat ACF.

Studies focused on evaluation of preload dependency found no association between E/e’ and fluid responsiveness. For example, Lamia et al ([14], Table3) found a similar E/e’ ratio between responder and non-responder patients, before and after volume expansion. Thus, we are not surprised to find a non-significant decrease of this parameter, after PLR, in both our groups.

Second part of Rewiewer1 remark:

We confirm our main outcome was ΔLV-Strain after PLR, and the study was designed on the hypothesis that ΔStrain after PLR would be greater in PLD+ group than in PLD-. Our hypothesis was already raised in the paper from Nafati and colleagues [21] showing that LV-GLS value increased after volume expansion in preload dependent patients.

Statistical analysis were based and designed on this only hypothesis.

4) Page 4 and 5. VTI after PLR is perhaps the most generalizable and generally the most accurate method of assessing preload responsiveness, but it is misleading to call it the gold standard. Please revise.

Response : Thank you for this comment.

Because the area under curve of VTI variations after PLR is almost perfect to predict fluid responsiveness, we chose this marker as a Gold standard to avoid unnecessary fluid loading in preload independent patients. However, according to your comment, we removed this term in the all manuscript.

5) Table 1: Sex is misspelled (Sexe).

Response : Noted.

*Comments from Reviewer#2

1) Title: It would be better to point out the subjects (patients with ACF) included in this study in the title. Additionally, the title should indicated the conclusion that variations in LV-LS after PLR is not a discriminating criterion to predict fluid responsiveness. Discuss the title in the letter to editor

Response : Revised title now includes details on the studied population.

Please refer to the letter to editor to find more details about discussion around the title.

2) Methods: fluid responsiveness should be defined in the Methods

Response: We used evaluation of preload dependency to predict fluid responsiveness, but did not assess fluid responsiveness in our cohort as patients did not receive any fluid. In the method section we defined what we considered preload-dependency : a LVOT-VTI variation greater than 10% after a passive leg raising maneuver, a validated method.

3) Results : (page13, line271): This study compared the variation of LV-LS in whole subjets after PLR. The variations of other parameters after PLR such as LV-SSR, RV-LS and LA-LS which were assessed by speckle tracking analysis should be added in this analysis to test their prediction value for fluid responsiveness.

Response: These data are now presented in the results section.

4) Results(page13, line270-274): Significant differences of mean LV-LS variations between T0 and T1 was observed in the whole population (n=60, p=0.04), but not in the PLD+ group (n=33, p=0.04) and PLD- group(n=27, p=0.25). Additionally, these variations of LV-LS after PLR were not statistically different between the groups (p=0.08)? The results might result from the small numbers of subjects, and statistical power test should be added in this study.

Response: We calculated the number of required subjects according to our primary goal which was to determine the sensitivity and specificity of LV-LS variations to assess preload dependency. We assumed, in accordance with literature, that 50% of our ACF population would be PLD+ and 50% PLD-, with roughly balanced groups. Taking that into account, for an aera under the curve > 0.85 with a confidence interval of 0.20 (CI 95% 0.75-0.95) and an alpha risk of 5% we found a required number of subjects of 60 with 50% in each group. Required number of subjects could not be calculated for the LV-LS variation, as we had no idea if 1) it would vary , and 2) in what proportion. These variations were never studied before. The “a posteriori” calculated required number of subjects, that would have been needed to ascertain a difference in LV-LS variation between our groups is 400. We, for sure, must acknowledge a lack of power... We added this important limitation in the discussion section.

5) Is there any liner correlation between variations of LV RVOT VTI and LV-LS after PLR?

Response : Unfortunatelly, no statistical correlation was found between LVOT-VTI variations and LV-LS variations after PLR.

- In the whole population (n=60) the Pearsons’ coefficient was 0.183, p = 0.161.

- In the PLD+ group (n=33) the

Pearsons’ coefficient was -0.015, p = 0.934

- In the PLD- group (n=27) the

Pearsons’ coefficient was -0.051, p = 0.800

6) Conclusion(page18, line384-385): This study did not test the correlations between LV-LS and afterload and intrinsic myocardial function. You should add related statistical analysis or modify the conclusion.

Response: Noted, we modified the conclusion

7) What is the advantages and innovations of this study?

Response: We built this observational study after the results of Nafati and colleagues’ study was published [21].

Indeed, that was the first time a study showed a variation of LV-GLS after a volume expansion in a preload dependent population of patients. We decided to question the problem from the other side and evaluate LV-LS variation after PLR as a predicting marker of preload dependency.

In current practice, LVOT-VTI variation after PRL is already a reliable marker, easy to learn and available at bedside in most situations. From that point of view, evaluation of the LV-LS variation could appear pointless.

But, two points must be discussed here.

First, this study shows that the Speckle tracking technology can be used in ICUs in clinical practice when available, as a simple tool that can precisely evaluate the systolic segmental function of the myocardium, following myocardial strain after severe myocarditis for example.

Cardiologists now use it as a routine evaluation.

Second, our study raises a caution here : interpretation of myocardial strain parameters in ICU patients implies that clinician should assess the haemodynamic status of the patients before analyzing any myocardial strain measurements.

Other : Journal requirements

PLOS ONE's style requirements: Instructions followed

What type of consent you obtained : Written consent was obtained after oral and written information

Competing interest section: Completed. Marc Leone, co-author, added his competing interest in this section as well.

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 1

Robert Ehrman

4 Aug 2021

PONE-D-21-11995R1

Left ventricular longitudinal strain variations assessed by speckle-tracking echocardiography after a passive leg raising maneuver in patients with acute circulatory failure  to predict fluid responsiveness: A prospective, observational study

PLOS ONE

Dear Dr. ROY,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

Thank you for your revisions. I am in agreement with Reviewer #1 in that the paper would be strengthened by including in the manuscript many of the responses to the reviewer comments the explain the underlying reasoning for many of the decisions that were made.

==============================

Please submit your revised manuscript by Sep 18 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Robert Ehrman, MD, MS

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments (if provided):

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: (No Response)

Reviewer #2: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: No

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: I thank the authors for responding to the comments raised by the editor and reviewers. I agree with many of their responses. However, the reason for raising these comments is that I expect other interested readers may ask similar questions. Therefore, while responding to the comments satisfies me, other readers won't have the same information unless they delve into the review history to see this. Please consider some minor revisions to the manuscript to include the important information you provide in your response.

Most of my comments were addressed obliquely with revisions made for the editor or other reviewer--there is mention of possible selection bias, and mention of the accuracy of PLR. However, the discordance between E/e' and PLR is of interest, and the authors respond wonderfully with a succinct description of the physiologic basis for why this could be discordant. I'd like to see that in the discussion. It would strengthen the plausibility of the findings and educate the readers. This merges well with the discussion of patient-level heterogeity.

Reviewer #2: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Sep 30;16(9):e0257737. doi: 10.1371/journal.pone.0257737.r004

Author response to Decision Letter 1


6 Sep 2021

*Academic Editor's remark:

Thank you for your revisions. I am in agreement with Reviewer #1 in that the paper would be strengthened by including in the manuscript many of the responses to the reviewer comments the explain the underlying reasoning for many of the decisions that were made.

*Reviewer#1 : I thank the authors for responding to the comments raised by the editor and reviewers. I agree with many of their responses. However, the reason for raising these comments is that I expect other interested readers may ask similar questions. Therefore, while responding to the comments satisfies me, other readers won't have the same information unless they delve into the review history to see this. Please consider some minor revisions to the manuscript to include the important information you provide in your response.

Most of my comments were addressed obliquely with revisions made for the editor or other reviewer--there is mention of possible selection bias, and mention of the accuracy of PLR. However, the discordance between E/e' and PLR is of interest, and the authors respond wonderfully with a succinct description of the physiologic basis for why this could be discordant. I'd like to see that in the discussion. It would strengthen the plausibility of the findings and educate the readers. This merges well with the discussion of patient-level heterogeneity.

** Answer and amendments :

Thank you for these perceptive remarks that helped us to clarify the discussion. In this new version of the manuscript, we tried to give more details to the readers about how the echocardiographic markers evaluated in ICU patients with acute circulatory failure, should be interpreted with caution.

Indeed, most markers that we use to assess preload-dependency, left ventricular end diastolic pressure, systolic or diastolic ventricular function, should be interpreted within the framework of the clinical history of the patient, and especially the aetiology of the circulatory failure.

Thus, we added a paragraph in the discussion section responding to reviewer#1 sensible remark concerning the relationship between E/e’ and preload, and about the E/e’ variations after a passive leg raising maneuver.

We also insisted, on the importance of the patient-level heterogeneity in the presented study, which is probably partly responsible for the negative results.

Therefore, this paragraph was added in the text:

“Regarding the usual echocardiographic markers that were evaluated at T0 and T1, there was a significant difference concerning cardiac output (and surrogates as LVOT-VTI) between the PLD+ and PLD-, but no significant difference was observed concerning echocardiographic markers of left-ventricular end diastolic pressure (LVEDP). Indeed, there was no difference between mean E, E’ lat, nor E/E’lat between PLD+ and PLD- and no significant variation of these markers between T0 and T1 in the whole population. Yet, some authors showed a relationship between E’lat and preload. Mahjoub et al. [45] showed a significant increase of E’lat (and a resultant decrease in E/E’lat) in a population of septic shock patients with diastolic dysfunction (E’Lat < 0.12cm/s) receiving a 500 ml crystalloid administration. These results suggest an improvement of LV relaxation with the correction of hypovolemia in patients with septic shock and diastolic dysfunction. Lamia et al. [14] studied the variations of echocardiographic markers of preload and LVEDP using a PLR maneuver, followed by a volume expansion and found similar results as ours, i.e. a non-significant variation of E, E’Lat and E/E’lat between responders and non-responders following PLR or crystalloid infusion. This study also concerned patients with various aetiology responsible for circulatory failure. Thus, if an increase of E’lat can be observed in preload-dependent patients after correcting hypovolemia, E/E’lat variation is not very accurate to quantify small transitory variations of preload and should rather be used as a marker of LVED, to anticipate the risk of fluid overload when a volume expansion is considered to treat ACF.”

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 2

Robert Ehrman

9 Sep 2021

Left ventricular longitudinal strain variations assessed by speckle-tracking echocardiography after a passive leg raising maneuver in patients with acute circulatory failure  to predict fluid responsiveness: A prospective, observational study

PONE-D-21-11995R2

Dear Dr. ROY,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Robert Ehrman, MD, MS

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Robert Ehrman

22 Sep 2021

PONE-D-21-11995R2

Left ventricular longitudinal strain variations assessed by speckle-tracking echocardiography after a passive leg raising maneuver in patients with acute circulatory failure  to predict fluid responsiveness: A prospective, observational study

Dear Dr. ROY:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Robert Ehrman

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: Response to Reviewers.docx

    Attachment

    Submitted filename: Response to Reviewers.docx

    Data Availability Statement

    The data file is held in the Open Science Framework repository at https://osf.io/e6tm4/.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES